Polaryx Therapeutics, Inc. Common Stock (NASDAQ: PLYX) — Healthcare · Share Price, Chart & Market Data
About: Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage novel gene therapy candidate. The company was founded in 2014 and is based in Paramus, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.85 (-8.83%)
PLYXPolaryx Therapeutics, Inc. Common Stock
Loading watchlist status…
Trade PLYX now
Polaryx Therapeutics, Inc. Common Stock share price
PLYX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:11 am GMT+0
PLYX price performance
-7.97%
5D
-37.741%
1M
-45.074%
YTD
-45.074%
1Y
PLYX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:11 am GMT+0
PLYX details
PLYX Market Signals